Gå direkt till innehåll

Nyhetsarkiv

Lokon Pharma develops cutting edge cancer immunotherapeutics

Lokon Pharma AB is a Swedish biotech company developing the LOAd platform of oncolytic adenoviruses genetically engineered to express immunostimulatory genes in malignant tumors and tumor stroma.

Lokon Pharma AB
Bredgränd 14
753 20 Uppsala
Sverige